Silence Therapeutics reported -28409000 in EBIT for its fiscal quarter ending in March of 2025.


Ebit Change Date
AstraZeneca USD 3.51B 1.3B Jun/2025
Autolus Therapeutics Ltd -82608000 17.37M Jun/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Novartis USD -9190000000 13.87B Jun/2025
Roche Holding CHF 11.29B 2.68B Jun/2024
Silence Therapeutics -28409000 894K Mar/2025